Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-141-4 | CAS number: 556-82-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- BASF SE; Experimental Toxicology and Ecology; Ludwigshafen; Germany
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 3-methylbut-2-en-1-ol
- EC Number:
- 209-141-4
- EC Name:
- 3-methylbut-2-en-1-ol
- Cas Number:
- 556-82-1
- Molecular formula:
- C5H10O
- IUPAC Name:
- 3-methylbut-2-en-1-ol
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Envigo, The Netherlands
- Age at study initiation: 11 weeks (pretest); 10 weeks (main test)
- Weight at study initiation: 17.5 g – 21.1 g (pretest); 17.3 g – 22.4 g (main test)
- Housing: 1 animal/cage
- Diet: ad libitum; Kliba mouse/rat maintenance diet “GLP" by Provimi Kliba SA,Switzerland.
- Water: ad libitum
- Acclimation period: min. 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 45-65
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- methyl ethyl ketone
- Concentration:
- 5%, 50%, 100% (Pretest)
25%, 50%, 100% (Main test) - No. of animals per dose:
- 2 (Pretest)
5 (Main test) - Details on study design:
- PRE-SCREEN TESTS:
- Assessment of compound solubility: Yes
- Assessment of clinical signs + local effects : Yes
- Body weight determination: Yes
- Ear thickness/weight measurements: Yes
- Lymph node weight measurements: Yes
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
Prior to first application, the animals were distributed to the individual groups, received their animal numbers and were allocated to the respective cages according to the randomization instructions of „Nijenhuis, A. and Wilf, H.S.: Combinatorial Algorithms, Academic Press, New York, San Francisco, London, 1978, pp. 62 – 64“.
TREATMENT PREPARATION AND ADMINISTRATION:
Body weight determination: Individual body weights on day 0 prior to the first application and on day 5 prior to the sacrifice of the animals.
Signs and symptoms: Obvious signs of systemic toxicity and/or local inflammation at the application sites were noted for each animal
Mortality: A check for moribund and dead animals was made twice each workday (beginning and end) and once on Saturdays, Sundays and on public holidays.
Form of application: Epicutaneous
Application volume: 25 µL per ear
Site of application: Dorsal part of both ears
Frequency of application: 3 consecutive applications (day 0 – day 2) to the same application site
On study day five (about 66 to 72 hours after the last application of test substance to the ears) the mice were injected into a tail vein with 20 µCi of 3H-thymidine in 250 µL of sterile saline.
- Parameters assessed:
Determination of ear weight:
Immediately after the death of each animal a circular piece of tissue (diameter 0.8 cm) was punched out of the apical part of each ear of all animals. The weight of the pooled punches was determined for each animal.
Removal and weight determination of the lymph nodes:
Immediately after removal of the ear punches the left and right auricular lymph nodes were dissected. The weight of the pooled lymph nodes from both sides was determined for each animal.
Preparation of cell suspension and determination of cell count:
After weight determination, the pooled lymph nodes of each animal were stored in phosphate buffered saline (PBS) and a single cell suspension was prepared by carefully passing the lymph nodes through an iron mesh (mesh size 200 µm) into phosphate-buffered physiological saline. The cell count was determined using a Casy®-Counter.
Measurement of 3H-thymidine incorporation of the lymph node cells:
The remaining cell suspensions were washed with PBS and precipitated with 5% trichloro-acetic acid (TCA). Each precipitate was measured in a β-scintillation counter.
- Criteria used to consider a positive response:
A test item is regarded as a sensitizer in the LLNA if exposure to at least one concentration of the test item results in an incorporation of 3H thymidine at least 3-fold or greater than that recorded in control mice, as indicated by the stimulation index (SI ≥ 3.0). However, the biological relevance of the obtained stimulation indices are considered in conjunction with the other assessed end points (i.e. cell counts, lymph node weights, ear weights). Hereby, the thresholds used for assessment of cell counts and ear weights are represented by stimulation indices (SI) of 1.5 and 1.25, respectively. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- 3H-thymidine incorporation, cell count, lymph node weight and ear weight: Wilcoxon - Test
Results and discussion
In vivo (LLNA)
Results
- Key result
- Parameter:
- EC3
- Value:
- 4.9
- Test group / Remarks:
- 3H-thymidine incorporation
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA
SI (3H-thymidin-incorporation)
25%: 1.01
50%: 1.81*
100%: 1.30
SI (cell counts)
25%: 1.02
50%: 1.26*
100%: 1.13
SI (lymph node weight)
25%: 0.94
50%: 1.19
100%: 1.04
EAR WEIGHTS
SI:
25%: 0.97
50%: 1.03
100%: 1.06
*p<=0.05; **p<=0.01
CLINICAL OBSERVATIONS:
No signs of systemic toxicity were noticed in all animals during general observation. No local findings were observed during the observation period.
BODY WEIGHTS:
The expected mean body weight gain was generally observed during the study.
Any other information on results incl. tables
Pretest / Irritation Screening -Results
No signs of systemic toxicity were observed. At the tested concentrations, the animals did not show relevant signs of local irritation as confirmed by the ear weight measurements (compared to current vehicle values) and ear thickness measurements. No increase in lymph node weights (compared to current vehicle values) were observed at 5% (SI 0.97) and 50% (SI 1.00). When applied undiluted, the SI for lymph node weights slightly increased (SI 1.38).
Applicant's summary and conclusion
- Executive summary:
The skin sensitizing potential of Prenol was assessed using the radioactive Murine Local Lymph Node Assay. Groups of 5 female CBA/CaOlaHsd mice each were treated with the undiluted test substance, 50% and 25% w/w preparations of the test substance in Methyl Ethyl Ketone (MEK) or with the vehicle, respectively. Additionally, untreated control animals were used for comparison versus animals of the high dose group (undiluted test substance). The study used 3 test groups and 2 control groups. Each test animal was treated with 25 μL per ear of the appropriate test-substance preparation or undiluted test substance, applied to the dorsal surface of both ears for three consecutive days. The vehicle control group was treated with 25 μL per ear of the vehicle. The second control group was untreated. Three days after the last application, 20 μCi 3H-thymidine in 250 μL sterile saline were injected into the tail vein of the mice. About 5 hours after the 3H-thymidine injection, the mice were sacrificed and the auricular lymph nodes were removed. Lymph node response was evaluated measuring 3H-thymidine incorporation (indicator of cell proliferation). Cell counts and weights of each animal’s pooled lymph nodes were also determined. In addition, a 0.8 cm diameter sample was punched out of the apical part of each ear, and for each animal, the weight of the pooled punches was determined to obtain an indication of possible skin irritation.
No signs of systemic toxicity were noticed in all animals during general observation. When applied undiluted or as 50% and 25% solution in MEK, the test substance did not induce a biologically relevant (no increase to 3-fold or above of control value = stimulation index (SI) ≥ 3) increase of 3H-thymidine incorporation into the cells from the auricular lymph nodes. Concomitantly no biologically relevant (no increase to 1.5-fold or above of control value = stimulation index (SI) ≥ 1.5) increase in lymph node cell counts was observed at all tested concentrations. However, statistically significant increases in 3H-thymidine incorporation and lymph node cell counts were noted at the 50% concentration. No relevant increase in lymph node weights was observed at all concentrations. The test-substance concentrations did not cause relevant increases in ear weights demonstrating the absence of ear skin irritation under the chosen testing conditions.
Overall, it is concluded that Prenol does not exhibit a skin sensitizing potential in the Murine Local Lymph Node Assay under the test conditions chosen.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.